Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cedar Psychiatry is a Utah-based outpatient mental health provider focused on psychiatry, psychotherapy, and interventional mental health services. The organization became known for ketamine-assisted psychotherapy and esketamine treatment, alongside broader offerings such as medication management, diagnostic evaluations, pharmacogenetic testing, and transcranial magnetic stimulation. It was founded in 2016 and expanded into a multi-clinic behavioral health network near Salt Lake City. Cedar Psychiatry was acquired by Novamind in July 2020, and Novamind itself was later acquired by Numinus in June 2022. The Cedar brand has since largely been absorbed into Numinus clinic operations, with several Utah locations described as formerly Cedar Psychiatry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cedar Psychiatry.